Avisa Diagnostics Inc.
A breath biomarker company developing a rapid, point-of-care test to detect pulmonary infections.
Avisa Diagnostics Inc. (AVBT)
Le 14 mai/May 2021
Avisa Diagnostics Inc., the issuer resulting from a Fundamental Change of FogChain Corp. (FOG.X), has been approved for listing.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
The Issuer offers an innovative approach to treating lung infections with rapid diagnostics to guide better clinical outcomes.